Share Name Share Symbol Market Type Share ISIN Share Description
Victrex Plc LSE:VCT London Ordinary Share GB0009292243 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 0.41% 2,466.00 2,458.00 2,462.00 2,490.00 2,426.00 2,490.00 189,312 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 294.0 104.7 107.2 23.0 2,132

Victrex Share Discussion Threads

Showing 26 to 50 of 600 messages
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
20/1/2002
19:17
Tightfist: "The Tax Efficient Review offers · In-depth reviews of ALL (my caps) new Venture Capital Trusts, Enterprise Investment Schemes, Capital Gains Tax deferral companies, Enterprise Zone Trusts and Film Partnerships · Coverage of the new AIM portfolio offerings based on the Inheritance Tax benefits of AIM investments" But of course, at a cost :£295pa, refunded when you've subbed £10k. Claim also to offer initial discounts, but (clearly) not refund any trail commission. Your comments re EIS re VCT are well taken. I'm happy with the (modest) tax-free returns on my VCTs - prob 7% pa on ~14 VCTs, from 1-5 years "old", tho' that calculated return includes the 20% tax break.... I'm in for 10 years (say); that comparison will be interesting. I'm also after a lower risk play, compared to some of my lumpy share holdings in PEPs/ISAs. I will take a closer look at EIS's however. DIY evaluation always has something to add!
spin doctor
20/1/2002
11:32
Sinso, I have been using Allenbridge, but with the defection of Martin Churchill to Credo Capital (www.taxefficientreview.com), I will probably go there now. But - I suspect they will only evaluate EIS's with a trail commission, which seem to be in the minority. So if EIS's are the way ahead (post 17) maybe DIY evaluation is best ?? Regards, tightfist
tightfist
19/1/2002
20:55
Do either of you use Bestinvest. I`ve gone for Unicorn AIM VCT and qualified for 2.25% discount. http://www.bestinvest.co.uk/vcts/FMPro?-db=webprices.fp5&-lay=newiss_info&-format=vct.htm&offer_open=y&fund_type=vct&-sortfield=invname&-sortorder=ascending&-find
sinso
19/1/2002
20:06
Spin Doctor, With all the VCT's being well down at the moment, I find it hard to ignore my (few) EIS's still being well up. The flexibility/visibility on Ofex-quoted EIS's is very attractive - there is also "serial relief" for trading within the 3 year limit, though I havn't tried using it yet. Maybe I have just hit a lucky streak, but I am seriously thinking of passing-by VCT's this year. Any other views on this ?? tightfist
tightfist
19/1/2002
12:18
What are ADVFNers up to re: VCTs this year? VCT market is subdued, reflecting low gains to shelter. Several VCTs comment that the price demanded by businesses for a stake is much lower than last year - surprise, surprise. NAVs of all VCTs have fallen, especially those with significant quoted and/or tech exposure. Any underlying growth in "intrinsic value", whatever that is, has been masked through a lack of exit opportunities. No rush to invest this year - all have a good way to go before full subscription. Quester 5, Baronsmead 4, Northern 3, Unicorn AIM and maybe Oxford Tech 3 are where my money's heading - generally well established in the VCT field, decent historical returns, nothing too fancy or focussed. Gartmore looks weak; Pathway has been slated (though treatment looks a bit harsh to me - I won't be investing in it however). This year there are no more conservative, income-seeking VCTs (such as Harvest last year, which failed to make its minimum). I've subscribed to www.taxefficient review.com's advice service. £295/year, but refunded when £10k subscribed, and discounts remain. Hasn't really altered my buying habits yet, but useful nonetheless. The single fee also gives reviews of each EIS issue.
spin doctor
02/7/2001
23:05
Breaking to a new high today?
m.t.glass
12/6/2001
13:55
Down 30p on results. How far do you think it will fall. M
milacs
12/6/2001
06:54
Today msm
msm
05/6/2001
10:46
does anyone know when the results are
max101
31/5/2001
19:58
bought some more today
ntv
30/5/2001
10:10
Prudential have just dumped another 125K That's 751K in just over 2 weeks When are the results, they're soon aren't they? Looks like PRU are hedging their bets a bit, though they've still got 11 million+
zzaxx99
23/5/2001
23:51
Prudential are continuing to reduce their stake - just dumped another 426K shares. Follows another 200K dropped 9 days ago.
zzaxx99
23/5/2001
12:32
Well we'll soon know if they are wise or not.
netcurtains
18/5/2001
08:19
Good morning Net I'm beginning to think that most pivate investors are still fixated with last years stocks, and expect them to suddenly return to last year's prices. Why aren't more people investing in tomorrows technology? (FCs are tried and tested, have really major advantages in terms of low pollution and efficiency, attract billions in government subsidies to launch the technology, are mentioned almost daily somewhere as a wide-ranging technology in diverse areas from battery replacement to the powerplant for zero polluting cars and low polluting, high availability and quality power stations). I can only conclude that people prefer to invest in puff rather than substance (perhaps most are puffing substances which affects their reasoning ability). Tax breaks for electric cars - perhaps some don't understand that this really means fuel cell cars? Blackouts in California - perhaps some don't understand that this will lead to massive sales of home and business-located individual back-up powerplants using fuel-cells. Very long-life, very quickly rechargeable batteries - perhaps some don't understand that these are micro-fuel cells. With almost daily positive comment, and almost weekly announcements of some major fuel-cell plant sale (it is now a commercial business), and only two years away until FC powered cars are sold commercially (and with a subsidy) it's only a matter of time before fuel cell stocks start to move. I would say that it makes sense for just about every portfolio to have some exposure to FCT, and there are a few FCT exposed companies with various risk profiles to enable this.
shy tott
17/5/2001
21:39
Hi, George Bush - BBC 10pm news tonight. He is giving tax breaks to Americans who buy electric cars. lol - there was even a large buy today as well.
netcurtains
11/5/2001
21:42
one product sole supplier globaly looks like a potential target for one of the big boys to me but what do i know dyor
ntv
11/5/2001
10:17
Net - I think you've got it right. IC said some odd things - 'Investment in additional capacity coming at the wrong time' - yeah sure, the directors are dummies who don't know as well as two bit journalists when the demand for their products is rising! Does the IC really expect less and less fuel cells to be produced in the future? 'One-product company' - I don't know whether Peek is a single polymer, or a set of similar polymers. The important thing is its product has applications in very diverse areas - metal replacement, medical instruments, fuel cell components, etc etc as their web site shows. 'Costs savings may be offset by higher research spending' - I don't know the trade-offs between these two, but I understood the new investment was quite conservative and easily manageable from their profits. I wouldn't like to invest in a high tech company which didn't have an R&d budget! Why I like VCT in particular is it is still verty proftable, even afer R&D spending. I tghink the bull points 'Sole supplier of PEEK plastic, Strong trading so far this year' are quite convincing. Overall, IC seems to be saying that 'VCT is a co with a fine trading record and a mkt-leadin product', but just overvalued in his opinion. But is a p/e of 22 overdone? for a profitable company with a good trading record, and exposed to fuel cells? I can think of lots of dross 'techs' with p/es in the hundreds! So, the 'sell' has hit the price a bit, causing about £70ks worth of sells. I think I'll hang on to these and wait for decent analysts to spot their quality and potential and put out some 'buys'. I suggest IC put the journalist back onto weddings and funerals where he may be more suited.
shy tott
11/5/2001
09:03
Gut feeling is... 1) Let the IC mag do its worst to the price. 2) Then buy. 3) then hold 3 to 4 years and see what happens.
netcurtains
11/5/2001
08:27
No - don't really know much about them - only got somewhat interested when net curtains mentioned them on the Sectoral Healing thread. At the moment, as ever, I'm awash with tech and pharm stocks - been looking around for things to diversify into, and on first sight VCT looked an interesting case. However, I don't really know much about the chem sector, so I'm a bit leery, especially after that IC piece (though as with all their tips, I take it with a pinch of salt). Have to say that their prediction of a slowdown on PEEK usage makes sense to me, and if you look back at their flat turnover prior to the last couple of years, that doesn't really inspire me at the moment. Plus points, I suppose, are their fuel cell exposure, but they don't seem like a terribly cheap way of getting into that arena - also looks a bit of an outside bet, though this is based on the comments in IC - haven't researched the company beyond the most superficial level. What's your views / reason for interest in them? Steve.
zzaxx99
11/5/2001
07:43
Thanks zzaxx99 for your quick response. Do you hold?
coolk4u
11/5/2001
07:28
According to IC: Bear points: One-product company exposed to industrial slow down Investment in additional capacity coming at the wrong time Costs savings may be offset by higher research spending Bull points Sole supplier of PEEK plastic Strong trading so far this year "It doesn't take much to be a star performer in the UK chem sector.... Victrex has bucked the trend ... last year .. 25% increase in pre-tax profits, while its share price has doubled over the last 18 months .... outlook is less rosy. ... is the only commercial manufacturer of PEEK ... when demand for PEEK is high .. business is very good .. but given the cyclical nature of VCT's industry, being a 1-product company can have its disadvantages ... after a strong recovery over the last couple of yearsm those markets are once again facing a downtturn ... Credit Lyonnais expects slowing sales in H2 this year .. counterbalanced by strong H1 ... consoiderably slower growth in 2001/2 ... exposure to the US ... is a particular concern. Telecomms equipments has been a high growth area ... but recent warnings from Cisco and Nortel ... Ford and GM [are worrying] ... with many economists expecting the US slowdown to spread to Europe ... it's hard to see how current sales of PEEK ... can be maintained. So ... plans to increase its global production capacity [by 50%] .. could backfire. ... has reduced ... exposure to cost pressure ... gains may be cancelled out by investment on new product. In Jan... signed a deal... to develop a variant of PEEK for use as a fuel cell membrane ... will spend at least £0.5m a year on R&D [to] 2004 ... building pilot .. .units will cost around £17m - should the project get betond research. Alternative energy is .. fashionable .. for investors ... joing the fuel cell bandwagon has helped ... share price .. possible ROI are stil far off. Make no mistake, VCT is a co with a fine trading record and a mkt-leadin product .. but everything comes at a price ... premium rating to the ... sector is just to high. Sell"
zzaxx99
11/5/2001
06:56
Sell recommendation in Investors Chronicle. Can anyone shed any light on this.
coolk4u
08/5/2001
14:33
Looks like someone just bought 100,000. Although you never can tell with individual trades. I have a few. Long term hold. I like the idea of FUEL CELLS technology as well as the MEDICAL APPLICATIONS
netcurtains
08/5/2001
10:43
I held shares in these yonks ago, long since sold, below a £1 I believe! Talking of where they belong, I'd put them closer to Aortech than BII, tough plastics for medical purposes and all that! Apart from that I no longer follow them, good stock though IMHO.
rayrac
08/5/2001
10:18
(Sorry if you've already this on the pharms sector thread, but this is probably a better place to discuss them) Regarding nc's comparison to BioCompatibles, do Victrex have any 'internal' applications (like BII's stents, for example)? I've just had a quick look at their web-site, and they're talking about surgical and dental instruments rather than (say) stents, valves or screws & plates for holding bones together etc. On another tack entirely, I'd not looked at these before John mentioned them, so I'm working from a position of virtually no knowledge. Can someone enlighten me on the recent history - the last couple of month's chart looks horrible - what was the cause of that big downward spike at the end of April? Steve.
zzaxx99
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1
Your Recent History
LSE
VCT
Victrex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200121 17:24:06